Mara Soraya Rodríguez-Evaristo

4PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyMedical virologySemi- and unsupervised learningBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 18, 2025
Effectiveness and safety of dolutegravir/lamivudine/abacavir versus bictegravir/emtricitabine/tenofovir alafenamide as first-line regimens in real-world settings (MICTLAN study).

José Antonio Mata-Marín, Mara Soraya Rodríguez-Evaristo, Ana Luz Cano-Díaz

|Feb 19, 2025
High Prevalence of Asymptomatic STIs in MSM PWH in a Male HIV Clinic in Mexico City.

Juan Pablo Sánchez Navarro, Gustavo Barriga Angulo, José Antonio Mata Marín

|Jul 27, 2024
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen.

José Antonio Mata-Marín, Carina Aurora Juárez-Contreras, Mara Soraya Rodríguez-Evaristo

|Sep 20, 2023
Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study.

José Antonio Mata Marín, Juan Carlos Velasco-Penagos, Stefan Mauss

Pageof 1

Frequent Collaborators

2 joint publications

Paola Edith Padilla-Noguera

2 joint publications

Ana Luz Cano-Díaz

1 joint publications

Juan Pablo Sánchez Navarro

1 joint publications

José Antonio Mata Marín